RunawayTrader

Rank amateur. Beginner. Newbie. Tyro. Whatever the term, I walked into Dendreon like I was making my first ever online trade. It’s a wonder I made any money at all, but wound up making lots of it, in spite of myself.
For new readers of this rag, you should know that I’ve been trading online since [...]

[Read more →]

I put a Post-It note on DNDN’s message board today in response to a group of posters embroiled in a brouhaha because Ameritrade raised its margin requirements on this stock, which, in turn, resulted in a broad discussion of the whole notion of betting only so many dollars as you can afford to lose.
The fellow [...]

[Read more →]

This Stock Could Buy You Your Own ‘Round-the-World Runaway
It looks like a sure thing. Nearly every Internet report I’m reading about Dendreon (DNDN) suggests that the FDA will soon announce approval of its prostate cancer drug, Provenge, (here’s a sample) and the word on the street is that its share price will bounce $10 or [...]

[Read more →]